Invesco Ltd. Akero Therapeutics, Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 115,788 shares of AKRO stock, worth $3.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

115,788

Previous 39,851 190.55%

Holding current value

$3.17 Million

Previous $1.01 Million 169.98%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$18.31 - $24.62 $1.39 Million - $1.87 Million	75,937 Added 190.55%	115,788 $2.72 Million
Q1 2024 May 14, 2024	BUY	$17.76 - $31.18 $202,464 - $355,452	11,400 Added 40.07%	39,851 $1.01 Million
Q4 2023 Feb 12, 2024	SELL	$11.38 - $50.33 $2.55 Million - $11.3 Million	-224,102 Reduced 88.73%	28,451 $664,000
Q3 2023 Nov 13, 2023	BUY	$41.19 - $52.25 $663,323 - $841,434	16,104 Added 6.81%	252,553 $12.8 Million
Q2 2023 Aug 11, 2023	BUY	$36.89 - $56.88 $8.03 Million - $12.4 Million	217,796 Added 1167.62%	236,449 $11 Million
Q1 2023 May 12, 2023	SELL	$37.27 - $50.24 $6.87 Million - $9.26 Million	-184,375 Reduced 90.81%	18,653 $713,000
Q4 2022 Feb 13, 2023	SELL	$33.44 - $54.8 $1.17 Million - $1.91 Million	-34,858 Reduced 14.65%	203,028 $11.1 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $2.41 Million - $8.1 Million	237,886 New	237,886 $8.1 Million
Q2 2022 Aug 15, 2022	SELL	$8.0 - $15.01 $84,680 - $158,880	-10,585 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.97 - $22.26 $2,023 - $3,472	156 Added 1.5%	10,585 $150,000
Q4 2021 Feb 14, 2022	SELL	$19.87 - $26.24 $24,380 - $32,196	-1,227 Reduced 10.53%	10,429 $221,000
Q3 2021 Nov 15, 2021	BUY	$18.65 - $25.46 $30,343 - $41,423	1,627 Added 16.22%	11,656 $260,000
Q2 2021 Aug 17, 2021	BUY	$24.81 - $32.35 $248,819 - $324,438	10,029 New	10,029 $249,000

Others Institutions Holding AKRO

# of Institutions

168

Shares Held

72.7M

Call Options Held

178K

Put Options Held

164K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.27B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account